Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies.

Casabonne D, Benavente Y, Costas L, Robles C, Gonzalez-Barca E, de la Banda E, Alonso E, Aymerich M, Campo E, Marcos-Gragera R, Tardón A, Olmedo-Requena R, Gimeno E, Martínez-López A, Casanovas O, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, de Sanjosé S.

Br J Haematol. 2018 Nov 19. doi: 10.1111/bjh.15583. [Epub ahead of print] No abstract available.

PMID:
30450673
2.

Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study.

Solans M, Castelló A, Benavente Y, Marcos-Gragera R, Amiano P, Gracia-Lavedan E, Costas L, Robles C, Gonzalez-Barca E, de la Banda E, Alonso E, Aymerich M, Campo E, Dierssen-Sotos T, Fernández-Tardón G, Olmedo-Requena R, Gimeno E, Castaño-Vinyals G, Aragonés N, Kogevinas M, de Sanjose S, Pollán M, Casabonne D.

Haematologica. 2018 Nov;103(11):1881-1888. doi: 10.3324/haematol.2018.192526. Epub 2018 Jun 28.

3.

Established and suggested exposures on CLL/SLL etiology: Results from the CLL-MCC-Spain study.

Benavente Y, Casabonne D, Costas L, Robles C, Alonso E, de la Banda E, Gonzalez-Barca E, Marcos-Gragera R, Llorca J, Tardón A, Monleon JJ, Aymerich M, Campo E, Gimeno-Vázquez E, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, de Sanjosé S.

Cancer Epidemiol. 2018 Feb;52:106-111. doi: 10.1016/j.canep.2017.12.012. Epub 2018 Jan 4.

PMID:
29289901
4.

The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells through the upregulation of NOXA and synergizes with ibrutinib, 5-aminoimidazole-4-carboxamide riboside or venetoclax.

Cosialls AM, Pomares H, Iglesias-Serret D, Saura-Esteller J, Núñez-Vázquez S, González-Gironès DM, de la Banda E, Preciado S, Albericio F, Lavilla R, Pons G, González-Barca EM, Gil J.

Haematologica. 2017 Sep;102(9):1587-1593. doi: 10.3324/haematol.2016.162958. Epub 2017 Jun 15.

5.

CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia.

Juncà J, Garcia O, Garcia-Caro M, Vila J, Zamora L, Cabezón M, Alonso E, de la Banda E, Rodríguez-Hernández I, Ribera JM, Millá F.

Ann Hematol. 2016 Dec;95(12):1949-1954. Epub 2016 Sep 5.

PMID:
27595757
6.

Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study.

Costas L, Benavente Y, Olmedo-Requena R, Casabonne D, Robles C, Gonzalez-Barca EM, de la Banda E, Alonso E, Aymerich M, Tardón A, Marcos-Gragera R, Gimeno-Vázquez E, Gómez-Acebo I, Papantoniou K, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, de Sanjosé S.

Int J Cancer. 2016 Nov 1;139(9):1994-2000. doi: 10.1002/ijc.30272. Epub 2016 Jul 27.

7.

Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.

Oliveira AC, Fernández de Sevilla A, Domingo A, De La Banda E, Domingo-Domènech E, Mercadal S, Ruiz-Xivillé N, Alonso E, Encuentra M, González-Barca E.

Ann Hematol. 2015 Apr;94(4):627-32. doi: 10.1007/s00277-014-2263-1. Epub 2014 Dec 5.

PMID:
25471173
8.

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.

Rozman M, Navarro JT, Arenillas L, Aventín A, Giménez T, Alonso E, Perea G, Camós M, Navarrete M, Tuset E, Florensa L, Millá F, Nomdedéu J, de la Banda E, Díaz-Beyá M, Pratcorona M, Garrido A, Navarro B, Brunet S, Sierra J, Esteve J; Grup Català de Citologia Hematològica and Spanish CETLAM Group (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas).

Ann Hematol. 2014 Oct;93(10):1695-703. doi: 10.1007/s00277-014-2100-6. Epub 2014 May 14.

PMID:
24824767
9.

Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Espinet B, Ferrer A, Bellosillo B, Nonell L, Salar A, Fernández-Rodríguez C, Puigdecanet E, Gimeno J, Garcia-Garcia M, Vela MC, Luño E, Collado R, Navarro JT, de la Banda E, Abrisqueta P, Arenillas L, Serrano C, Lloreta J, Miñana B, Cerutti A, Florensa L, Orfao A, Sanz F, Solé F, Dominguez-Sola D, Serrano S.

Clin Cancer Res. 2014 Feb 15;20(4):1007-19. doi: 10.1158/1078-0432.CCR-13-1077. Epub 2013 Dec 18.

10.

Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells.

Pérez-Perarnau A, Coll-Mulet L, Rubio-Patiño C, Iglesias-Serret D, Cosialls AM, González-Gironès DM, de Frias M, de Sevilla AF, de la Banda E, Pons G, Gil J.

Epigenetics. 2011 Oct 1;6(10):1228-35. doi: 10.4161/epi.6.10.17200. Epub 2011 Oct 1.

PMID:
21931276
11.

[Persistent polyclonal B-cell lymphocytosis: study of 35 cases].

Florensa L, Navarro JT, Pérez Vila ME, Domingo A, De la Banda E, Rozman M, Camós M, Millá F, Perea G, Alonso E, Ayats R, Aventín A, Cabezudo E, Espinet B, Merino A, Romero P, Sánchez C, Tuset E, Solé F, Feliu E, Fernández C, Gallart M, Vallespí T, Woessner S.

Med Clin (Barc). 2011 May 14;136(13):565-73. doi: 10.1016/j.medcli.2010.09.048. Epub 2011 Mar 10. Spanish.

PMID:
21396665
12.

Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.

Oliveira AC, de la Banda E, Domingo-Domenech E, Encuentra M, Mercadal S, Domingo A, Alonso E, Espinet B, Grau J, De Sevilla AF, Gonzalez-Barca E.

Leuk Lymphoma. 2011 Mar;52(3):429-35. doi: 10.3109/10428194.2010.545463.

PMID:
21323523
13.

[Acute hepatitis and fever].

Girbau A, Baliellas C, Castellote J, de la Banda E.

Enferm Infecc Microbiol Clin. 2010 Oct;28(8):556-7. doi: 10.1016/j.eimc.2009.12.010. Epub 2010 Apr 8. Spanish. No abstract available.

PMID:
20381209
14.

Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.

de Frias M, Iglesias-Serret D, Cosialls AM, González-Gironès DM, Pérez-Perarnau A, Rubio-Patiño C, Rückle T, Camps M, de Sevilla AF, de la Banda E, Pons G, Gil J.

Br J Haematol. 2010 Jul;150(1):108-11. doi: 10.1111/j.1365-2141.2010.08151.x. Epub 2010 Mar 11. No abstract available.

PMID:
20230409
15.

Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells.

de Frias M, Iglesias-Serret D, Cosialls AM, Coll-Mulet L, Santidrián AF, González-Gironès DM, de la Banda E, Pons G, Gil J.

Haematologica. 2009 Dec;94(12):1698-707. doi: 10.3324/haematol.2008.004028. Epub 2009 Oct 8.

16.

Liver transplantation across Rh blood group barriers increases the risk of biliary complications.

Busquets J, Castellote J, Torras J, Fabregat J, Ramos E, Llado L, Rafecas A, de la Banda E, Figueras J.

J Gastrointest Surg. 2007 Apr;11(4):458-63.

17.

IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.

Ferrà C, de Sanjosé S, Gallardo D, Berlanga JJ, Rueda F, Marìn D, de la Banda E, Ancìn I, Peris J, Garcìa J, Grañena A.

Haematologica. 1998 Dec;83(12):1082-7.

18.

Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.

Boqué C, Petit J, Sarrá J, Cancelas JA, Muñoz J, Español JI, de la Banda E, Aventin A, Berlanga J, Ferrá C, Amill B, Torrico C, Azqueta C, Llucià M, García J, Grañena A.

Bone Marrow Transplant. 1996 Nov;18(5):879-84.

PMID:
8932840
19.

Bone marrow transplantation without protective environment: evaluation of infectious complications.

Gallardo D, Alonso E, Español I, de la Banda E, Ferrá C, Berlanga JJ, Grañena A.

Transplant Proc. 1995 Aug;27(4):2353. No abstract available.

PMID:
7544502

Supplemental Content

Loading ...
Support Center